A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Office of the Assistant Secretary for Preparedness and Response
- Biomedical Advanced Research and Development Authority
- Department of Health and Human Services
- VaxInnate Corporation
This publication has 16 references indexed in Scilit:
- Structural Basis of TLR5-Flagellin Recognition and SignalingScience, 2012
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellinVaccine, 2009
- Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal NeedsPLOS ONE, 2008
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motilityNature Immunology, 2003
- Complete atomic model of the bacterial flagellar filament by electron cryomicroscopyNature, 2003
- Gram-negative Flagellin-induced Self-tolerance Is Associated with a Block in Interleukin-1 Receptor-associated Kinase Release from Toll-like Receptor 5Journal of Biological Chemistry, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Activation of Interleukin-1 Receptor-Associated Kinase by Gram-Negative FlagellinInfection and Immunity, 2001